 mesenteric and hepatic ischemia
early after CA coverage. (Ungraded good practice
statement)
Recommendation for access during TEVAR
Importantly, access-related issues remain a common
source of morbidity after TEVAR, although these complications are certainly decreasing with the increasing
lubricity and decreasing diameter of device delivery systems. In several early multicenter, industry-sponsored
trials, procedural failures ranged from 0.5% to 2% and
were almost all